Granulocyte-colony Stimulating Factor Attenuates Oligomeric Amyloid β Neurotoxicity by Activation of Neprilysin
Overview
Authors
Affiliations
Soluble oligomeric amyloid β (oAβ) causes synaptic dysfunction and neuronal cell death, which are involved in the pathogenesis of Alzheimer's disease (AD). The hematopoietic growth factor granulocyte-colony stimulating factor (G-CSF) is expressed in the central nervous system (CNS) and drives neurogenesis. Here we show that G-CSF attenuated oAβ neurotoxicity through the enhancement of the enzymatic activity of Aβ-degrading enzyme neprilysin (NEP) in neurons, while the NEP inhibitor thiorphan abolished the neuroprotection. Inhibition of MEK5/ERK5, a major downstream effector of G-CSF signaling, also ablated neuroprotective effect of G-CSF. Furthermore, intracerebroventricular administration of G-CSF enhanced NEP enzymatic activity and clearance of Aβ in APP/PS1 transgenic mice. Thus, we propose that G-CSF may be a possible therapeutic strategy against AD.
Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.
Nehra G, Bauer B, Hartz A Pharmacol Ther. 2022; 234:108119.
PMID: 35108575 PMC: 9107516. DOI: 10.1016/j.pharmthera.2022.108119.
Colony stimulating factors in the nervous system.
Chitu V, Biundo F, Stanley E Semin Immunol. 2021; 54:101511.
PMID: 34743926 PMC: 8671346. DOI: 10.1016/j.smim.2021.101511.
Neuroprotection through G-CSF: recent advances and future viewpoints.
Rahi V, Jamwal S, Kumar P Pharmacol Rep. 2021; 73(2):372-385.
PMID: 33389706 DOI: 10.1007/s43440-020-00201-3.
Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.
Xin S, Tan L, Cao X, Yu J, Tan L Neurotox Res. 2018; 34(3):733-748.
PMID: 29626319 DOI: 10.1007/s12640-018-9895-1.
Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET.
Barron A, Tokunaga M, Zhang M, Ji B, Suhara T, Higuchi M J Neuroinflammation. 2016; 13(1):221.
PMID: 27578213 PMC: 5006247. DOI: 10.1186/s12974-016-0700-x.